Nursing care
Donepezil: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Donepezil is a cholinesterase inhibitor used to slow cognitive decline in Alzheimer disease; it does not reverse existing damage or cure the condition. Give it at bedtime to reduce nausea, and monitor heart rate closely, since donepezil can cause bradycardia through increased vagal tone. Hold and report a pulse below 60.
Why this drug and not another
Donepezil blocks the breakdown of acetylcholine in the brain, raising levels of a neurotransmitter that is already depleted in Alzheimer disease. That extra acetylcholine supports the cognitive circuits still functioning, which is why families sometimes see a plateau or a modest improvement in memory and orientation after starting therapy.
Set expectations early. Donepezil slows the rate of decline; it does not reverse the disease process or restore lost neurons. A patient who continues to decline, only more slowly than they would have without treatment, is a treatment success, not a treatment failure. Nurses who understand this distinguish it clearly for families who expect a cure.
Administration and timing
Give donepezil once daily at bedtime. Nausea, vomiting, and diarrhoea are the most common adverse effects, and dosing at night means the patient sleeps through the peak GI irritation rather than experiencing it during waking hours.
It can be taken with or without food. Tablets and orally disintegrating tablets are both available; the disintegrating form is useful for patients with dysphagia, a common concern in advanced dementia. Dose increases typically happen no sooner than every four to six weeks, since steady-state levels take time to establish and GI tolerance needs time to develop.
Monitoring parameters
Check apical pulse before each dose during initiation and after any dose increase. Donepezil increases vagal tone, and bradycardia is a recognised effect, not a rare idiosyncratic one. Hold the dose and notify the prescriber for a pulse below 60 or for new dizziness and syncope.
Weigh the patient periodically and track oral intake, since ongoing GI upset can lead to weight loss in a population already at nutritional risk. In a patient with known cardiac conduction disease, an ECG before and during treatment is reasonable, since bradycardia can unmask or worsen sick sinus syndrome.
Adverse effects to report
Report bradycardia, syncope, or falls immediately, since these point to the cardiac effect of cholinergic excess. Also report signs of GI bleeding, black tarry stools, or persistent vomiting, because donepezil increases gastric acid secretion and can unmask a peptic ulcer.
Muscle cramps and increased urinary frequency are known but usually tolerable effects tied to the same cholinergic mechanism. New or worsening seizure activity should also be reported, since cholinesterase inhibitors lower the seizure threshold in susceptible patients.
Contraindications and cautions
Use donepezil cautiously in patients with sick sinus syndrome or other conduction abnormalities, given the bradycardia risk. Caution also applies in active peptic ulcer disease or a history of GI bleeding, in asthma or COPD due to the cholinergic effect on bronchial secretions, and in patients with a seizure disorder.
Donepezil is metabolised through the liver, so dose adjustment or closer monitoring is warranted in hepatic impairment. It has no renal dose adjustment requirement, which distinguishes it from several other drugs commonly used in an elderly population with reduced renal clearance.
Teaching points the exam tests
NCLEX questions on donepezil usually centre on two things: bedtime dosing to manage GI effects, and pulse checks to catch bradycardia before it causes syncope. Expect a question asking what to assess before administering the next dose, with apical pulse as the correct answer.
Teach the family that donepezil slows decline rather than reversing it, so they do not stop the drug out of disappointment when cognition does not improve. Teach them to report a slow or irregular pulse, fainting, or black stools, and to never stop the drug abruptly without discussing it with the prescriber, since discontinuation can accelerate cognitive decline.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our neurological practice questions are the closest set to what this page covers.
Common questions
Does donepezil reverse Alzheimer disease?
No. Donepezil slows the rate of cognitive decline by increasing available acetylcholine, but it does not repair existing neuronal damage or cure the underlying disease. Some patients see a temporary plateau or mild improvement, but the disease continues to progress.
Why is donepezil given at bedtime?
Bedtime dosing reduces the impact of nausea, vomiting, and diarrhoea, which are the most common adverse effects. The patient sleeps through the period of peak GI irritation instead of experiencing it while awake.
What pulse rate should stop a donepezil dose?
Hold the dose and notify the prescriber for a pulse below 60 beats per minute. Donepezil increases vagal tone and can cause clinically significant bradycardia, particularly in patients with existing conduction disease.
Can donepezil cause GI bleeding?
Yes. Donepezil increases gastric acid secretion through its cholinergic effect, which can aggravate or unmask peptic ulcer disease. Report black tarry stools or persistent vomiting to the prescriber promptly.